Chordate Medical Holding AB Cash Flow-to-Debt Ratio
Chordate Medical Holding AB cash flow-to-debt ratio. Chordate Medical Holding AB (CMH) has a Cash Flow-to-Debt Ratio of -1.72x as of June 2025, meaning its operating cash flow of Skr-7.14 Million could theoretically repay -2% of its total liabilities (Skr4.14 Million) in one year. See financial agility of Chordate Medical Holding AB to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Chordate Medical Holding AB (2015–2024)
Cash flow-to-debt ratio of Chordate Medical Holding AB from 2015 to 2024. Historical debt coverage capacity for Chordate Medical Holding AB across 10 annual periods. Also explore Chordate Medical Holding AB equity growth rate to track the company's year-over-year net asset growth rate.
Chordate Medical Holding AB Cash Flow-to-Debt Ratio by Year (2015–2024)
Chordate Medical Holding AB cash flow-to-debt ratio by year from 2015 to 2024. Year-by-year debt coverage analysis for Chordate Medical Holding AB. For the full cash flow conversion analysis, see CMH cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.93x | Skr-24.41 Million | Skr8.34 Million | ▲ +26.2% |
| 2023 | -3.97x | Skr-27.26 Million | Skr6.87 Million | ▼ -20.3% |
| 2022 | -3.30x | Skr-24.98 Million | Skr7.57 Million | ▲ +17.0% |
| 2021 | -3.98x | Skr-20.34 Million | Skr5.11 Million | ▼ -27.3% |
| 2020 | -3.13x | Skr-17.43 Million | Skr5.58 Million | ▼ -45.2% |
| 2019 | -2.15x | Skr-16.95 Million | Skr7.87 Million | ▼ -11.7% |
| 2018 | -1.93x | Skr-18.99 Million | Skr9.86 Million | ▼ -10.7% |
| 2017 | -1.74x | Skr-18.99 Million | Skr10.91 Million | ▼ -109.0% |
| 2016 | -0.83x | Skr-9.64 Million | Skr11.58 Million | ▲ +20.3% |
| 2015 | -1.05x | Skr-12.42 Million | Skr11.89 Million | — |